Pulmonary thromboembolism with massive vaginal bleeding due to thrombolytic therapy.
Thrombolytic therapy may reduce the morbidity of pulmonary thromboembolism (PTE) and the risk of recurrent disease. The most important complication of thrombolytic therapy is bleeding. We report a patient with PTE complicated by massive vaginal bleeding due to thrombolytic therapy.
Ekim
Numan
N
Gazi University School of Medicine, Department of Pulmonary Diseases, Ankara, Turkey. nekim@superonline.com
Kokturk
Nurdan
N
Yegin
Demet
D
Kokturk
Oguz
O
Habesoglu
M Ali
MA
D000028:Abortion, Induced; D000328:Adult; D000075202:Contraindications; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects* / Q000627:therapeutic use; D014592:Uterine Hemorrhage / Q000139:chemically induced* / Q000628:therapy; D016306:Vena Cava Filters
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator